- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/48 - Hydrolases (3.) acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4)
Patent holdings for IPC class C12N 9/48
Total number of patents in this class: 852
10-year publication summary
40
|
42
|
40
|
57
|
44
|
68
|
92
|
83
|
94
|
36
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3344 |
26 |
The Trustees of the University of Pennsylvania | 4366 |
16 |
Centre National de La Recherche Scientifique | 10595 |
14 |
Northwestern University | 3430 |
13 |
Regeneron Pharmaceuticals, Inc. | 4370 |
13 |
The Regents of the University of California | 20153 |
11 |
Formycon AG | 44 |
10 |
Commissariat à l'énergie atomique et aux energies alternatives | 10959 |
8 |
DuPont Nutrition Biosciences ApS | 474 |
8 |
Spogen Biotech Inc. | 139 |
8 |
Encodia, Inc. | 103 |
8 |
University of Florida Research Foundation, Inc. | 4055 |
7 |
Danisco US Inc. | 1120 |
7 |
Health Research, Inc. | 342 |
7 |
Universite Grenoble Alpes | 745 |
7 |
DSM IP Assets B.V. | 5572 |
6 |
Ajinomoto Co., Inc. | 2306 |
6 |
Dana-Farber Cancer Institute, Inc. | 2602 |
6 |
Renescience A/S | 41 |
6 |
The Procter & Gamble Company | 21996 |
5 |
Other owners | 660 |